Angiotensin had the highest market share in the hypertension drug segment and was worth about 41 billion Indian rupees in financial year 2020. Beta Blockers had the second highest market value among the drug classes in hypertension that same year.
Value of hypertension market across India in financial year 2020, by drug class (in billion Indian rupees)
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$189 USD $149 USD / Month *
in the first 12 months
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Cardiovascular disease in India
Overview
5
- Premium Statistic Deaths caused by chronic diseases 2019
- Basic Statistic Prevalence of select risk factors in cardiovascular disease deaths worldwide in 2016
- Basic Statistic Market share of cardiac market India FY 2020, by drug type
- Basic Statistic Market share of cardiac sales India FY 2020, by leading company
- Basic Statistic Penetrated market share in cardiac segment India FY 2020, by leading company
Heart disease
5
- Premium Statistic Share of people with heart problems India 2020, by age group
- Premium Statistic Share of people with cholesterol and heart problems India 2020, by gender
- Premium Statistic Risk of heart problems India 2019 by body mass index
- Premium Statistic Impact of cholesterol on heart issues among Indians 2019
- Premium Statistic Number of cases of heart disease in senior citizens India 2011-2050
Hypertension
4
- Premium Statistic Number of cases of hypertension in senior citizens India 2011-2050
- Premium Statistic Chronic disease incidence to treatment India 2019, by disease type
- Basic Statistic Value of hypertension market India FY 2020, by drug class
- Basic Statistic Share of hypertension market India FY 2020, by drug class
Leading cardiac therapies
4
- Basic Statistic Share of hypertension market India FY 2020, by drug class
- Basic Statistic Value of hyperlipidemia market India FY 2020, by drug class
- Basic Statistic Value of hypertension market India FY 2020, by drug class
- Basic Statistic Value of anti-thrombotic market India FY 2020, by drug class
Leading cardiac brands and molecules
7
- Basic Statistic Market value of leading brand in the cardiac segment India FY 2020
- Basic Statistic Market value of leading molecules in the cardiac segment India FY 2020
- Basic Statistic Market value of leading fastest growing molecules in cardiac segment India FY 2020
- Basic Statistic Number of one billion rupee brands in the cardiac segment India FY 2016-2020
- Basic Statistic Number of 500 million rupee brands in the cardiac segment India FY 2016-2020
- Basic Statistic Share of top five molecules in cardiac therapy India FY 2016-2020
- Basic Statistic Share of top ten molecules in cardiac therapy India FY 2016-2020
Leading market players
7
- Basic Statistic Glenmark Pharma' share of cardiac in IPM FY 2011-20
- Basic Statistic JB Chemicals' share of cardiac in IPM FY 2011-20
- Basic Statistic Dr.Reddy's laboratories' share of cardiac in Indian pharmaceutical market FY 2011-20
- Basic Statistic Cipla's share of cardiac in Indian pharmaceutical market FY 2011-2020
- Basic Statistic Lupin's share of cardiac in Indian pharmaceutical market FY 2011-2020
- Basic Statistic Torrent Pharmaceutical share of cardiac in Indian pharmaceutical market FY 2011-2020
- Basic Statistic Sun Pharmaceuticals' share of cardiac in Indian pharmaceutical market FY 2011-2020
Further related statistics
18
- Global osteoporosis drug market size from 2014 to 2022, by drug type
- Antihypertensive pharmaceutical consumption in Austria 2010-2017
- Antihypertensive pharmaceutical consumption in Portugal 2005-2018
- Leading antianginal drugs dispensed in England 2022, by item number
- Antihypertensives pharmaceutical consumption in Spain 2008-2022
- Drug cost distribution by drug type in public drug plans Canada 2020/2021
- Drug price changes in the U.S. by product group until end-2019
- Antihypertensive pharmaceutical consumption in the Netherlands 2005-2017
- Public drug program spending share for seniors in Canada by top drug classes 2021
- Antihypertensive pharmaceutical consumption in Germany 2009-2021
- Public drug program spending in Canada by top drug classes 2021
- Antihypertensive pharmaceutical consumption in Hungary 2007-2022
- Public drug program spending in Canada by top 10 drug classes 2021
- Antihypertensive pharmaceutical consumption in Luxembourg 2009-2022
- Prevalence of self-reported hypertension in the U.S. in 2017, by age
- Controlled hypertension in adults in U.S. 2015-2016, by age and gender
- Gout therapeutics market share U.S. by drug type 2015-2025
- Prevalence of hypertension in rural India FY 2012, by region
Further Content: You might find this interesting as well
Statistics
- Global osteoporosis drug market size from 2014 to 2022, by drug type
- Antihypertensive pharmaceutical consumption in Austria 2010-2017
- Antihypertensive pharmaceutical consumption in Portugal 2005-2018
- Leading antianginal drugs dispensed in England 2022, by item number
- Antihypertensives pharmaceutical consumption in Spain 2008-2022
- Drug cost distribution by drug type in public drug plans Canada 2020/2021
- Drug price changes in the U.S. by product group until end-2019
- Antihypertensive pharmaceutical consumption in the Netherlands 2005-2017
- Public drug program spending share for seniors in Canada by top drug classes 2021
- Antihypertensive pharmaceutical consumption in Germany 2009-2021
- Public drug program spending in Canada by top drug classes 2021
- Antihypertensive pharmaceutical consumption in Hungary 2007-2022
- Public drug program spending in Canada by top 10 drug classes 2021
- Antihypertensive pharmaceutical consumption in Luxembourg 2009-2022
- Prevalence of self-reported hypertension in the U.S. in 2017, by age
- Controlled hypertension in adults in U.S. 2015-2016, by age and gender
- Gout therapeutics market share U.S. by drug type 2015-2025
- Prevalence of hypertension in rural India FY 2012, by region
HDFC Securities. (September 29, 2020). Value of hypertension market across India in financial year 2020, by drug class (in billion Indian rupees) [Graph]. In Statista. Retrieved September 23, 2023, from https://www.statista.com/statistics/1201895/india-value-of-hypertension-market-by-type/
HDFC Securities. "Value of hypertension market across India in financial year 2020, by drug class (in billion Indian rupees)." Chart. September 29, 2020. Statista. Accessed September 23, 2023. https://www.statista.com/statistics/1201895/india-value-of-hypertension-market-by-type/
HDFC Securities. (2020). Value of hypertension market across India in financial year 2020, by drug class (in billion Indian rupees). Statista. Statista Inc.. Accessed: September 23, 2023. https://www.statista.com/statistics/1201895/india-value-of-hypertension-market-by-type/
HDFC Securities. "Value of Hypertension Market across India in Financial Year 2020, by Drug Class (in Billion Indian Rupees)." Statista, Statista Inc., 29 Sep 2020, https://www.statista.com/statistics/1201895/india-value-of-hypertension-market-by-type/
HDFC Securities, Value of hypertension market across India in financial year 2020, by drug class (in billion Indian rupees) Statista, https://www.statista.com/statistics/1201895/india-value-of-hypertension-market-by-type/ (last visited September 23, 2023)
Value of hypertension market across India in financial year 2020, by drug class (in billion Indian rupees) [Graph], HDFC Securities, September 29, 2020. [Online]. Available: https://www.statista.com/statistics/1201895/india-value-of-hypertension-market-by-type/